Looking forward to next week, when Thalocan Research Innovations CEO Eric Zudak heads to 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. And when it comes to cutting edge, TRI is proud to deliver TRICOA, the first…
DetailsThe Story Behind the Science A Conversation with Paul Stroili, Vice President of Creative by Ginger Claremohr, Claremohr Writing Co. A Life in Stories Long before he was helping shape the visual identity of Thalocan Research Innovations, Paul Stroili was telling stories from a stage. For more than four decades, he has worked as an…
DetailsThalocan Research Innovations CEO Eric Zudak is heading to New York City, July 16–19, for The 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. One breakthrough sure to be discussed is the enthusiastic response to our Lesion…
DetailsToday is World Vitiligo Day, a global campaign dedicated to raising awareness, ending social stigma, and advocating for people living with vitiligo. Originally launched in 2011, the day unites the international community to promote research and support for those affected. At Thalocan Research Innovations Research Innovtions, we applaud the work of the GLOBAL VITILIGO FOUNDATION…
DetailsThalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and Tyler White are looking forward to an exciting few days at the Revolutionizing Atopic Dermatitis Conference (RAD 2026) in Nashville. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Our TRI team will…
DetailsSpeaking the Same Language: Continuous Improvement at Every Level A conversation with Maggie Ellis, founder of Fluent Fox Language Solutions and a valued partner in Thalocan’s culture of continuous improvement. by Ginger Claremohr, Claremohr Writing Co. Long Before Brazil When Maggie Ellis traveled to Brazil, she described the experience as something that felt, in her…
DetailsVitiligo Awareness Month, observed throughout June, is a global campaign dedicated to educating the public about the autoimmune disease, fighting social stigma, and supporting those living with the condition. All of us here at Thalocan Research Innovations applaud the work of the Vitiligo Research Foundation, among others so essential in spreading awareness and insight about…
DetailsJune is Myasthenia Gravis (MG) Awareness Month. This annual campaign is designed to increase public understanding of this neuromuscular autoimmune disease, support those living with it, and raise funds for research. Here at Thalocan Research Innovations. we were proud to partner with Dr. Richard Barohn, Dr. Gil Wolfe and Instructor Laura Herbelin in creating Thalocan’s…
DetailsThalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and 🚀 Tyler White White will be attending RAD 2026 in Nashville, an event co-chaired by one of our collaborators, Dr. Jonathan Silverberg We are currently in post-production with two trainings led by Dr. Silverberg: The Eczema Area & Severity Index (EASI) and the Validated Investigator…
DetailsSean Morrison leads Customer Enablement and Support at Thalocan Research Innovations where he is responsible for ensuring that customers are equipped to successfully implement and operationalize clinical trial endpoint management solutions. He focuses on translating complex clinical processes into clear, actionable workflows that drive consistency, accuracy, and measurable outcomes across studies… To learn more about…
Details
